Literature DB >> 8264985

Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease.

J R Connor1, P Tucker, M Johnson, B Snyder.   

Abstract

In the present study we observed a loss in excess of 1/3 of the copper transport and anti-oxidant protein ceruloplasmin in both the gray and white matter from superior temporal gyrus in Alzheimer's diseased brains compared to age-matched controls. A decrease in ceruloplasmin could be reflected in decreased cellular metabolic processes such as the electron transport system and a decrease in the ability of the brain to protect itself from oxidative damage. Both decreased metabolic activity and an increase in oxidative insults are known to be associated with the neurological events in Alzheimer's disease, but the mechanism by which these phenomena occur are unknown. These results coupled with previous reports from this laboratory on iron regulatory proteins in the brain suggests one way in which cellular dysfunction and oxidative stress occurs in AD may be through a loss of ability to maintain a balance of essential metals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264985     DOI: 10.1016/0304-3940(93)90805-u

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Does ceruloplasmin differential express in the brain of Ts65Dn: a mouse mode of Down syndrome?

Authors:  Bin Yu; Jing Kong; Baoling Xing; Ziqiang Zhu; Bin Zhang; Qiu-Wei Wang; Shi-He Shao
Journal:  Neurol Sci       Date:  2013-11-17       Impact factor: 3.307

2.  Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.

Authors:  H Kessler; F-G Pajonk; P Meisser; T Schneider-Axmann; K-H Hoffmann; T Supprian; W Herrmann; R Obeid; G Multhaup; P Falkai; T A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

Review 3.  Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.

Authors:  Erin J McAllum; David I Finkelstein
Journal:  J Mol Neurosci       Date:  2016-08-08       Impact factor: 3.444

4.  The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons.

Authors:  Changyi Ji; Brittany L Steimle; Danielle K Bailey; Daniel J Kosman
Journal:  Cell Mol Neurobiol       Date:  2017-11-25       Impact factor: 5.046

5.  Measurement of acute phase proteins in the rat brain: contribution of vascular contents.

Authors:  D A Loeffler; M C Linder; M Zamany; E Harel; M A Paul; H Baumann; P A LeWitt
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

6.  Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease.

Authors:  F J Jiménez-Jiménez; F de Bustos; J A Molina; J Benito-León; A Tallón-Barranco; T Gasalla; M Ortí-Pareja; F Guillamón; J C Rubio; J Arenas; R Enríquez-de-Salamanca
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 7.  Metals and amyloid-beta in Alzheimer's disease.

Authors:  Christa J Maynard; Ashley I Bush; Colin L Masters; Roberto Cappai; Qiao-Xin Li
Journal:  Int J Exp Pathol       Date:  2005-06       Impact factor: 1.925

Review 8.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

9.  Ceruloplasmin/Transferrin ratio changes in Alzheimer's disease.

Authors:  Rosanna Squitti; Carlo Salustri; Mariacristina Siotto; Mariacarla Ventriglia; Fabrizio Vernieri; Domenico Lupoi; Emanuele Cassetta; Paolo M Rossini
Journal:  Int J Alzheimers Dis       Date:  2010-12-27

10.  Mining disease genes using integrated protein-protein interaction and gene-gene co-regulation information.

Authors:  Jin Li; Limei Wang; Maozu Guo; Ruijie Zhang; Qiguo Dai; Xiaoyan Liu; Chunyu Wang; Zhixia Teng; Ping Xuan; Mingming Zhang
Journal:  FEBS Open Bio       Date:  2015-03-27       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.